Trial Profile
A study to evaluate the efficacy and safety of single or repeated cycles of intravenous Iloprost in patients with Thromboangiitis obliterans
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Thromboangiitis obliterans
- Focus Adverse reactions; Therapeutic Use
- 21 Dec 2015 New trial record